COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

July 26, 2020
Preprint
Open Access

Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study

MedRxiv : the Preprint Server for Health Sciences
Michele DonatoD. Perlin
July 22, 2020
Comment / Editorial
Open Access

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials

Critical Care : the Official Journal of the Critical Care Forum
Manu Shankar-HariUnited Kingdom SARS-CoV-2 Convalescent Plasma Evaluation (SCoPE) Consortium
July 23, 2020
Review
Open Access

Pharmaco-Immunomodulatory Therapy in COVID-19

Drugs
John G RizkDonald N Forthal
July 17, 2020
Preprint
Open Access

Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection

MedRxiv : the Preprint Server for Health Sciences
K. WangAi-Long Huang
July 25, 2020
Preprint
Open Access

High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2

BioRxiv : the Preprint Server for Biology
Bernard VanhoveJ.-P. Soulillou
July 28, 2020
Review
Open Access

Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Priyadarsini J ArcotArulselvi Subramanian
July 20, 2020

Advances in the possible treatment of COVID-19: A review

European Journal of Pharmacology
Pankaj ChibberGurdarshan Singh
July 20, 2020
Preprint
Open Access

Initial experience in Mexico with convalescent plasma in COVID-19 patients with severe respiratory failure, a retrospective case series

MedRxiv : the Preprint Server for Health Sciences
M. F. Martinez-ResendezGuillermo Torre-Amione
July 19, 2020
Open Access

Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with COVID-19 in New York City

The Journal of Pediatrics
Kim R DerespinaShivanand S Medar
July 22, 2020
Review
Open Access

Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?

Diagnosis
Nour Majbour, Omar El-Agnaf
July 22, 2020
Open Access

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

The Journal of Experimental Medicine
Fabian SchmidtPaul D Bieniasz
July 11, 2020
Preprint
Open Access

A simple protein-based SARS-CoV-2 surrogate neutralization assay

BioRxiv : the Preprint Server for Biology
July 23, 2020
Open Access

Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Hassan AbolghasemiSamira Shahverdi
July 30, 2020
Open Access

Convalescent Plasma: Promise for COVID-19 Pandemic

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Sadaf Sheikh, Muhammad Akbar Baig
July 14, 2020
Review
Open Access

Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era

Virusdisease
Dinesh Kumar RajendranDharun Kasilingam

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

COVID-19 Neurologic Manifestations

COVID-19 patients frequently have neurological symptoms, which are probably caused by the virus invading the central nervous system. Symptoms range from a loss of smell and taste to serious complications such as encephalitis, many of which are associated with poor prognosis. This feed follows the latest developments and research into the neurological complications associated with COVID-19.

© 2020 Meta ULC. All rights reserved
/feed-previews/covid-19-covalescent-plasma-therapy/9f06ec2a-0b2a-44e7-b15d-4926bd88eebc